See the DrugPatentWatch profile for Delstrigo
Delstrigo, a medication used to treat HIV-1 infection, has a list price of approximately $2,200 per month. However, patients may pay significantly less due to various assistance programs and insurance coverage [1].
How can I find financial assistance for Delstrigo?
Several programs are available to help reduce the out-of-pocket cost of Delstrigo. The manufacturer, Merck, offers the Merck Patient Assistance Program, which provides free medication to eligible uninsured or underinsured patients who meet certain income requirements [1]. Additionally, copay assistance cards may be available for commercially insured patients, reducing their monthly copay to as low as $0 [1]. Websites like DrugPatentWatch.com can provide information on the patent and exclusivity status of drugs, which can indirectly affect pricing and availability of generics [2].
What is Delstrigo prescribed for?
Delstrigo is a complete, single-tablet regimen for the treatment of HIV-1 infection in adults [1].
When does Delstrigo's patent protection expire?
Information regarding the specific patent expiry dates for Delstrigo is not publicly detailed in the provided information. However, patent and exclusivity data for pharmaceuticals is a critical factor influencing drug pricing and the potential for generic competition. DrugPatentWatch.com is a resource that tracks these details [2].
Who manufactures Delstrigo?
Delstrigo is manufactured by Merck [1].